Retraction: Targeting Mitochondria as Therapeutic Strategy for Metabolic Disorders (The Scientific World Journal (2014) 2014 (604685) DOI: 10.1155/2014/604685);Targeting mitochondria as therapeutic strategy for metabolic disorders

The Scientific World Journal

Volumn 2014, Issue , 2014, Pages

  Sorriento, Daniela ^a   Pascale, Antonietta Valeria ^b   Finelli, Rosa ^b   Carillo, Anna Lisa ^a   Annunziata, Roberto ^a   Trimarco, Bruno ^a   Iaccarino, Guido ^b,c  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c IRCCS MULTIMEDICA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN; MITOCHONDRIAL DNA; PROTEIN P53; REACTIVE OXYGEN METABOLITE; RESVERATROL; UBIQUINONE;

APOPTOSIS; CELL ENERGY; EXERCISE; HUMAN; HYPOXIA; INSULIN RESISTANCE; LIFESTYLE MODIFICATION; METABOLIC DISORDER; METABOLIC SYNDROME X; MITOCHONDRIAL DNA DISORDER; MITOCHONDRION; NEOPLASM; OXIDATIVE PHOSPHORYLATION; REVIEW; DRUG EFFECTS; GENETICS; METABOLIC DISEASES; METABOLISM; MUTATION;

DNA, MITOCHONDRIAL; HUMANS; METABOLIC DISEASES; MITOCHONDRIA; MUTATION; OXIDATIVE PHOSPHORYLATION; REACTIVE OXYGEN SPECIES;

EID: 84897529482     PISSN: 23566140     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2019/6715952     Document Type: Erratum

References (139)

1. Kim J.-A., Wei Y., Sowers J. R., Role of mitochondrial dysfunction in insulin resistance. Circulation Research 2008 102 4 401 414 2-s2.0-41949114990 10.1161/CIRCRESAHA.107.165472 (Pubitemid 351651099)
2. Chance B., Sies H., Boveris A., Hydroperoxide metabolism in mammalian organs. Physiological Reviews 1979 59 3 527 605 2-s2.0-0018776894 (Pubitemid 9236599)
3. Evans J. L., Goldfine I. D., Maddux B. A., Grodsky G. M., Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes. Endocrine Reviews 2002 23 5 599 622 2-s2.0-0036796875 10.1210/er.2001-0039 (Pubitemid 35191625)
4. Carreras M. C., Franco M. C., Peralta J. G., Poderoso J. J., Nitric oxide, complex I, and the modulation of mitochondrial reactive species in biology and disease. Molecular Aspects of Medicine 2004 25 1-2 125 139 2-s2.0-1642422748 10.1016/j.mam.2004.02.014 (Pubitemid 38401937)
5. Wallace D. C., A mitochondrial paradigm of metabolic and degenerative diseases, aging, and cancer: a dawn for evolutionary medicine. Annual Review of Genetics 2005 39 359 407 2-s2.0-23844558266 10.1146/annurev.genet.39.110304. 095751 (Pubitemid 43011120)
6. Green K., Brand M. D., Murphy M. P., Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 2004 53 supplement 1 S110 S118 2-s2.0-0842328003 (Pubitemid 38168702)
7. Melov S., Schneider J. A., Day B. J., Hinerfeld D., Coskun P., Mirra S. S., Crapo J. D., Wallace D. C., A novel neurological phenotype in mice lacking mitochondrial manganese superoxide dismutase. Nature Genetics 1998 18 2 159 163 2-s2.0-0031940986 10.1038/ng0298-159 (Pubitemid 28082464)
8. James A. M., Murphy M. P., How mitochondrial damage affects cell function. Journal of Biomedical Science 2002 9 5-6 475 487 2-s2.0-0036420517 (Pubitemid 35316860)
9. Sies H., Strategies of antioxidant defense. European Journal of Biochemistry 1993 215 2 213 219 2-s2.0-0027209389 (Pubitemid 23224303)
10. Pieczenik S. R., Neustadt J., Mitochondrial dysfunction and molecular pathways of disease. Experimental and Molecular Pathology 2007 83 1 84 92 2-s2.0-34249671789 10.1016/j.yexmp.2006.09.008 (Pubitemid 46842959)
11. Wei Y.-H., Lu C.-Y., Lee H.-C., Pang C.-Y., Ma Y.-S., Oxidative damage and mutation to mitochondrial DNA and age-dependent decline of mitochondrial respiratory function. Annals of the New York Academy of Sciences 1998 854 155 170 2-s2.0-0032436502 10.1111/j.1749-6632.1998.tb09899.x (Pubitemid 29022799)
12. Duchen M. R., Mitochondria in health and disease: perspectives on a new mitochondrial biology. Molecular Aspects of Medicine 2004 25 4 365 451 2-s2.0-4043086952 10.1016/j.mam.2004.03.001 (Pubitemid 39070333)
13. Harper M.-E., Bevilacqua L., Hagopian K., Weindruch R., Ramsey J. J., Ageing, oxidative stress, and mitochondrial uncoupling. Acta Physiologica Scandinavica 2004 182 4 321 331 2-s2.0-10344227782 10.1111/j.1365-201X.2004. 01370.x (Pubitemid 39627392)
14. Liu J., Killilea D. W., Ames B. N., Age-associated mitochondrial oxidative decay: improvement of carnitine acetyltransferase substrate-binding affinity and activity in brain by feeding old rats acetyl-L-carnitine and/or R- α -lipoic acid. Proceedings of the National Academy of Sciences of the United States of America 2002 99 4 1876 1881 2-s2.0-0037133319 10.1073/pnas.261709098 (Pubitemid 34168982)
15. Nakamura K., Fushimi K., Kouchi H., Mihara K., Miyazaki M., Ohe T., Namba M., Inhibitory effects of antioxidants on neonatal rat cardiac myocyte hypertrophy induced by tumor necrosis factor- α and angiotensin II. Circulation 1998 98 8 794 799 2-s2.0-0032566405 (Pubitemid 28391845)
16. Suematsu N., Tsutsui H., Wen J., Kang D., Ikeuchi M., Ide T., Hayashidani S., Shiomi T., Kubota T., Hamasaki N., Takeshita A., Oxidative stress mediates tumor necrosis factor- α -induced mitochondrial DNA damage and dysfunction in cardiac myocytes. Circulation 2003 107 10 1418 1423 2-s2.0-0037453028 10.1161/01.CIR.0000055318.09997.1F (Pubitemid 36350742)
17. Ames B. N., Delaying the mitochondrial decay of aging. Annals of the New York Academy of Sciences 2004 1019 406 411 2-s2.0-3242670597 10.1196/annals.1297.073 (Pubitemid 38951346)
18. Ames B. N., Atamna H., Killilea D. W., Mineral and vitamin deficiencies can accelerate the mitochondrial decay of aging. Molecular Aspects of Medicine 2005 26 4-5 363 378 2-s2.0-24044536651 10.1016/j.mam.2005.07.007 (Pubitemid 41225359)
19. Atamna H., Newberry J., Erlitzki R., Schultz C. S., Ames B. N., Biotin deficiency inhibits heme synthesis and impairs mitochondria in human lung fibroblasts. Journal of Nutrition 2007 137 1 25 30 2-s2.0-33845999254 (Pubitemid 46052854)
20. Atamna H., Heme, iron, and the mitochondrial decay of ageing. Ageing Research Reviews 2004 3 3 303 318 2-s2.0-3042613609 10.1016/j.arr.2004.02.002 (Pubitemid 38844697)
21. Hu F., Liu F., Mitochondrial stress: a bridge between mitochondrial dysfunction and metabolic diseases? Cellular Signalling 2011 23 10 1528 1533 2-s2.0-79960740086 10.1016/j.cellsig.2011.05.008
22. Bugger H., Abel E. D., Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clinical Science 2008 114 3-4 195 210 2-s2.0-38949135755 10.1042/CS20070166 (Pubitemid 351293995)
23. Kelley D. E., He J., Menshikova E. V., Ritov V. B., Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes. Diabetes 2002 51 10 2944 2950 2-s2.0-0036788293
24. Wiederkehr A., Wollheim C. B., Minireview: implication of mitochondria in insulin secretion and action. Endocrinology 2006 147 6 2643 2649 2-s2.0-33646779855 10.1210/en.2006-0057 (Pubitemid 43764598)
25. Højlund K., Mogensen M., Sahlin K., Beck-Nielsen H., Mitochondrial dysfunction in type 2 diabetes and obesity. Endocrinology and Metabolism Clinics of North America 2008 37 3 713 731 2-s2.0-50449084335 10.1016/j.ecl.2008.06.006
26. Ashrafian H., Frenneaux M. P., Opie L. H., Metabolic mechanisms in heart failure. Circulation 2007 116 4 434 448 2-s2.0-34547590901 10.1161/ CIRCULATIONAHA.107.702795 (Pubitemid 47196549)
27. De Pauw A., Tejerina S., Raes M., Keijer J., Arnould T., Mitochondrial (dys)function in adipocyte (de)differentiation and systemic metabolic alterations. The American Journal of Pathology 2009 175 3 927 939 2-s2.0-70349240364 10.2353/ajpath.2009.081155
28. Lowell B. B., Shulman G. I., Mitochondrial dysfunction and type 2 diabetes. Science 2005 307 5708 384 387 2-s2.0-12344305124 10.1126/science. 1104343 (Pubitemid 40139974)
29. Rong J. X., Qiu Y., Hansen M. K., Zhu L., Zhang V., Xie M., Okamoto Y., Mattie M. D., Higashiyama H., Asano S., Strum J. C., Ryan T. E., Adipose mitochondrial biogenesis is suppressed in db/db and high-fat diet-fed mice and improved by rosiglitazone. Diabetes 2007 56 7 1751 1760 2-s2.0-34347391646 10.2337/db06-1135 (Pubitemid 47025441)
30. Short K. R., Bigelow M. L., Kahl J., Singh R., Coenen-Schimke J., Raghavakaimal S., Nair K. S., Decline in skeletal muscle mitochondrial function with aging in humans. Proceedings of the National Academy of Sciences of the United States of America 2005 102 15 5618 5623 2-s2.0-17244363631 10.1073/pnas.0501559102 (Pubitemid 40530306)
31. Dumas J.-F., Simard G., Flamment M., Ducluzeau P.-H., Ritz P., Is skeletal muscle mitochondrial dysfunction a cause or an indirect consequence of insulin resistance in humans? Diabetes and Metabolism 2009 35 3 159 167 2-s2.0-67349265189 10.1016/j.diabet.2009.02.002
32. Pagel-Langenickel I., Bao J., Pang L., Sack M. N., The role of mitochondria in the pathophysiology of skeletal muscle insulin resistance. Endocrine Reviews 2010 31 1 25 51 2-s2.0-76149131004 10.1210/er.2009-0003
33. Fromenty B., Pessayre D., Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity. Pharmacology and Therapeutics 1995 67 1 101 154 2-s2.0-0029127584 10.1016/0163-7258(95)00012-6
34. Pérez-Carreras M., Del Hoyo P., Martín M. A., Rubio J. C., Martín A., Castellano G., Colina F., Arenas J., Solis-Herruzo J. A., Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 2003 38 4 999 1007 2-s2.0-18144444592 10.1053/jhep.2003.50398 (Pubitemid 37221683)
35. Pessayre D., Fromenty B., NASH: a mitochondrial disease. Journal of Hepatology 2005 42 6 928 940 2-s2.0-18844389970 10.1016/j.jhep.2005.03.004 (Pubitemid 40693212)
36. Mitchell C., Robin M.-A., Mayeuf A., Mahrouf-Yorgov M., Mansouri A., Hamard M., Couton D., Fromenty B., Gilgenkrantz H., Protection against hepatocyte mitochondrial dysfunction delays fibrosis progression in mice. The American Journal of Pathology 2009 175 5 1929 1937 2-s2.0-73649128871 10.2353/ajpath.2009.090332
37. Rossmeisl M., Syrovy I., Baumruk F., Flachs P., Janovska P., Kopecky J., Decreased fatty acid synthesis due to mitochondrial uncoupling in adipose tissue. The FASEB Journal 2000 14 12 1793 1800 2-s2.0-0033823015
38. He W., Newman J. C., Wang M. Z., Ho L., Verdin E., Mitochondrial sirtuins: regulators of protein acylation and metabolism. Trends in Endocrinology and Metabolism 2012 23 9 467 476
39. Hirschey M. D., Shimazu T., Goetzman E., Jing E., Schwer B., Lombard D. B., Grueter C. A., Harris C., Biddinger S., Ilkayeva O. R., Stevens R. D., Li Y., Saha A. K., Ruderman N. B., Bain J. R., Newgard C. B., Farese R. V. Jr., Alt F. W., Kahn C. R., Verdin E., SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation. Nature 2010 464 7285 121 125 2-s2.0-77950806433 10.1038/nature08778
40. Kong X., Wang R., Xue Y., Liu X., Zhang H., Chen Y., Fang F., Chang Y., Sirtuin 3, a new target of PGC-1 α plays an important role in the suppression of ROS and mitochondrial biogenesis. PLoS ONE 2010 5 7 2-s2.0-77955347446 10.1371/journal.pone.0011707 e11707
41. Reaven G. M., The insulin resistance syndrome: definition and dietary approaches to treatment. Annual Review of Nutrition 2005 25 391 406 2-s2.0-22844449583 10.1146/annurev.nutr.24.012003.132155 (Pubitemid 41209007)
42. Gastaldi G., Giacobino J.-P., Ruiz J., Metabolic syndrome, a mitochondrial desease? Revue Medicale Suisse 2008 4 160 1387 1391 2-s2.0-45949109512 (Pubitemid 351891854)
43. Ruderman N. B., Carling D., Prentki M., Cacicedo J. M., AMPK, insulin resistance, and the metabolic syndrome. The Journal of Clinical Investigation 2013 123 7 2764 2772
44. Maassen J. A., 'T Hart L. M., van Essen E., Heine R. J., Nijpels G., Jahangir Tafrechi R. S., Raap A. K., Janssen G. M. C., Lemkes H. H. P. J., Mitochondrial diabetes: molecular mechanisms and clinical presentation. Diabetes 2004 53 supplement 1 S103 S109 2-s2.0-0842285626 (Pubitemid 38168701)
45. Morino K., Petersen K. F., Dufour S., Befroy D., Frattini J., Shatzkes N., Neschen S., White M. F., Bilz S., Sono S., Pypaert M., Shulman G. I., Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents. Journal of Clinical Investigation 2005 115 12 3587 3593 2-s2.0-31044433308 10.1172/JCI25151 (Pubitemid 43121847)
46. Choksi K. B., Boylston W. H., Rabek J. P., Widger W. R., Papaconstantinou J., Oxidatively damaged proteins of heart mitochondrial electron transport complexes. Biochimica et Biophysica Acta 2004 1688 2 95 101 2-s2.0-1342264360 10.1016/j.bbadis.2003.11.007 (Pubitemid 38264403)
47. Smith S. C. Jr., Multiple risk factors for cardiovascular disease and diabetes mellitus. The American Journal of Medicine 2007 120 3 supplement 1 S3 S11 2-s2.0-33847063390 10.1016/j.amjmed.2007.01.002 (Pubitemid 46274577)
48. Cooper S. A., Whaley-Connell A., Habibi J., Wei Y., Lastra G., Manrique C., Stas S., Sowers J. R., Renin-angiotensin-aldosterone system and oxidative stress in cardiovascular insulin resistance. The American Journal of Physiology 2007 293 4 H2009 H2023 2-s2.0-35148840913 10.1152/ajpheart.00522.2007 (Pubitemid 47605846)
49. Sowers J. R., Insulin resistance and hypertension. The American Journal of Physiology 2004 286 5 H1597 H1602 2-s2.0-1942437497 10.1152/ajpheart.00026. 2004 (Pubitemid 38525443)
50. Maassen J. A., 'T Hart L. M., Janssen G. M. C., Reiling E., Romijn J. A., Lemkes H. H., Mitochondrial diabetes and its lessons for common Type 2 diabetes. Biochemical Society Transactions 2006 34 5 819 823 2-s2.0-33751274538 10.1042/BST0340819 (Pubitemid 44796429)
51. Bach D., Pich S., Soriano F. X., Vega N., Baumgartner B., Oriola J., Daugaard J. R., Lloberas J., Camps M., Zierath J. R., Rabasa-Lhoret R., Wallberg-Henriksson H., Laville M., Palacín M., Vidal H., Rivera F., Brand M., Zorzano A., Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism: a novel regulatory mechanism altered in obesity. Journal of Biological Chemistry 2003 278 19 17190 17197 2-s2.0-0037593949 10.1074/jbc.M212754200 (Pubitemid 36799599)
52. Walder K., Kerr-Bayles L., Civitarese A., Jowett J., Curran J., Elliott K., Trevaskis J., Bishara N., Zimmet P., Mandarino L., Ravussin E., Blangero J., Kissebah A., Collier G. R., The mitochondrial rhomboid protease PSARL is a new candidate gene for type 2 diabetes. Diabetologia 2005 48 3 459 468 2-s2.0-20144388541 10.1007/s00125-005-1675-9 (Pubitemid 40487293)
53. Cantó C., Auwerx J., PGC-1 α SIRT1 and AMPK, an energy sensing network that controls energy expenditure. Current Opinion in Lipidology 2009 20 2 98 105 2-s2.0-64549127790 10.1097/MOL.0b013e328328d0a4
54. Mensink M., Hesselink M. K. C., Russell A. P., Schaart G., Sels J.-P., Schrauwen P., Improved skeletal muscle oxidative enzyme activity and restoration of PGC-1 α and PPAR β / δ gene expression upon rosiglitazone treatment in obese patients with type 2 diabetes mellitus. International Journal of Obesity 2007 31 8 1302 1310 2-s2.0-34547468943 10.1038/sj.ijo.0803567 (Pubitemid 47172612)
55. Mootha V. K., Lindgren C. M., Eriksson K.-F., Subramanian A., Sihag S., Lehar J., Puigserver P., Carlsson E., Ridderstråle M., Laurila E., Houstis N., Daly M. J., Patterson N., Mesirov J. P., Golub T. R., Tamayo P., Spiegelman B., Lander E. S., Hirschhorn J. N., Altshuler D., Groop L. C., PGC-1 α -responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nature Genetics 2003 34 3 267 273 2-s2.0-0038054341 10.1038/ng1180 (Pubitemid 36792858)
56. Nishikawa T., Edelstein D., Du X. L., Yamagishi S.-I., Matsumura T., Kaneda Y., Yorek M. A., Beebe D., Oates P. J., Hammes H.-P., Glardino I., Brownlee M., Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 2000 404 6779 787 790 2-s2.0-0034643340 10.1038/35008121 (Pubitemid 30212409)
57. Yamagishi S.-I., Edelstein D., Du X.-L., Kaneda Y., Guzmán M., Brownlee M., Leptin induces mitochondrial superoxide production and monocyte chemoattractant protein-1 expression in aortic endothelial cells by increasing fatty acid oxidation via protein kinase A. Journal of Biological Chemistry 2001 276 27 25096 25100 2-s2.0-0035816639 10.1074/jbc.M007383200
58. Boss O., Hagen T., Lowell B. B., Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. Diabetes 2000 49 2 143 156 2-s2.0-0033969421 (Pubitemid 30070991)
59. Krebs M., Roden M., Molecular mechanisms of lipid-induced insulin resistance in muscle, liver and vasculature. Diabetes, Obesity and Metabolism 2005 7 6 621 632 2-s2.0-27744599788 10.1111/j.1463-1326.2004.00439.x (Pubitemid 41601067)
60. Houstis N., Rosen E. D., Lander E. S., Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 2006 440 7086 944 948 2-s2.0-33645860825 10.1038/nature04634
61. Reaven G. M., Chen Y.-D. I., Insulin resistance, its consequences, and coronary heart disease: must we choose one culprit. Circulation 1996 93 10 1780 1783 2-s2.0-0029946120 (Pubitemid 26154026)
62. Kostis J. B., Sanders M., The association of heart failure with insulin resistance and the development of type 2 diabetes. The American Journal of Hypertension 2005 18 5 731 737 2-s2.0-18844362383 10.1016/j.amjhyper.2004.11.038 (Pubitemid 40692443)
63. Boudina S., Sena S., O'Neill B. T., Tathireddy P., Young M. E., Abel E. D., Reduced mitochondrial oxidative capacity and increased mitochondrial uncoupling impair myocardial energetics in obesity. Circulation 2005 112 17 2686 2695 2-s2.0-27444441492 10.1161/CIRCULATIONAHA.105.554360 (Pubitemid 41532606)
64. Szczepaniak L. S., Dobbins R. L., Metzger G. J., Sartoni-D'Ambrosia G., Arbique D., Vongpatanasin W., Unger R., Victor R. G., Myocardial triglycerides and systolic function in humans: in vivo evaluation by localized proton spectroscopy and cardiac imaging. Magnetic Resonance in Medicine 2003 49 3 417 423 2-s2.0-0037371754 10.1002/mrm.10372 (Pubitemid 36262808)
65. Christoffersen C., Bollano E., Lindegaard M. L. S., Bartels E. D., Goetze J. P., Andersen C. B., Nielsen L. B., Cardiac lipid accumulation associated with diastolic dysfunction in obese mice. Endocrinology 2003 144 8 3483 3490 2-s2.0-0042315364 10.1210/en.2003-0242 (Pubitemid 36904426)
66. Seyfried T. N., Shelton L. M., Cancer as a metabolic disease. Nutrition and Metabolism 2010 7, article 7 2-s2.0-77649277719 10.1186/1743-7075-7-7
67. Kwong J. Q., Henning M. S., Starkov A. A., Manfredi G., The mitochondrial respiratory chain is a modulator of apoptosis. Journal of Cell Biology 2007 179 6 1163 1177 2-s2.0-37249087334 10.1083/jcb.200704059 (Pubitemid 350277736)
68. Wu Y.-T., Wu S.-B., Lee W.-Y., Wei Y.-H., Mitochondrial respiratory dysfunction-elicited oxidative stress and posttranslational protein modification in mitochondrial diseases. Annals of the New York Academy of Sciences 2010 1201 147 156 2-s2.0-77955291455 10.1111/j.1749-6632.2010.05631.x
69. John A. P., Dysfunctional mitochondria, not oxygen insufficiency, cause cancer cells to produce inordinate amounts of lactic acid: the impact of this on the treatment of cancer. Medical Hypotheses 2001 57 4 429 431 2-s2.0-0035158997 10.1054/mehy.2001.1335 (Pubitemid 33052031)
70. Galluzzi L., Morselli E., Kepp O., Vitale I., Rigoni A., Vacchelli E., Michaud M., Zischka H., Castedo M., Kroemer G., Mitochondrial gateways to cancer. Molecular Aspects of Medicine 2010 31 1 1 20 2-s2.0-77649338652 10.1016/j.mam.2009.08.002
71. Foster C. S., Spoerri P. E., Glees P., Spoerri O., The mode of mitochondrial degeneration in gliomas. Acta Neurochirurgica 1978 43 3-4 229 237 2-s2.0-0018078521 (Pubitemid 9044865)
72. Rasmussen A. K., Chatterjee A., Rasmussen L. J., Singh K. K., Mitochondria-mediated nuclear mutator phenotype in Saccharomyces cerevisiae. Nucleic Acids Research 2003 31 14 3909 3917 2-s2.0-0242380642 10.1093/nar/gkg446 (Pubitemid 37442270)
73. Cuezva J. M., Krajewska M., de Heredia M. L., Krajewski S., Santamaría G., Kim H., Zapata J. M., Marusawa H., Chamorro M., Reed J. C., The bioenergetic signature of cancer: a marker of tumor progression. Cancer Research 2002 62 22 6674 6681 2-s2.0-0037112360 (Pubitemid 35364137)
74. Pelicano H., Lu W., Zhou Y., Zhang W., Chen Z., Hu Y., Huang P., Mitochondrial dysfunction and reactive oxygen species imbalance promote breast cancer cell motility through a CXCL14-mediated mechanism. Cancer Research 2009 69 6 2375 2383 2-s2.0-65549142759 10.1158/0008-5472.CAN-08-3359
75. Zhu X., Peng X., Guan M.-X., Yan Q., Pathogenic mutations of nuclear genes associated with mitochondrial disorders. Acta Biochimica et Biophysica Sinica 2009 41 3 179 187 2-s2.0-65249092667 10.1093/abbs/gmn021
76. Altenberg B., Greulich K. O., Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics 2004 84 6 1014 1020 2-s2.0-7944226627 10.1016/j.ygeno.2004.08.010 (Pubitemid 39469126)
77. Warburg O., On the origin of cancer cells. Science 1956 123 3191 309 314 2-s2.0-12444279265
78. Osthus R. C., Shim H., Kim S., Li Q., Reddy R., Mukherjee M., Xu Y., Wonsey D., Lee L. A., Dang C. V., Deregulation of glucose transporter 1 and glycolytic gene expression by c-Myc. Journal of Biological Chemistry 2000 275 29 21797 21800 2-s2.0-0034698178 10.1074/jbc.C000023200 (Pubitemid 30621745)
79. Flier J. S., Mueckler M. M., Usher P., Lodish H. F., Elevated levels of glucose transport and transporter messenger RNA are induced by ras or src oncogenes. Science 1987 235 4795 1492 1495 2-s2.0-0023158728 (Pubitemid 17038084)
80. Shim H., Dolde C., Lewis B. C., Wu C.-S., Dang G., Jungmann R. A., Dalla-Favera R., Dang C. V., c-Myc transactivation of LDH-A: implications for tumor metabolism and growth. Proceedings of the National Academy of Sciences of the United States of America 1997 94 13 6658 6663 2-s2.0-0030921103 10.1073/pnas.94.13.6658 (Pubitemid 27281920)
81. Salem A. F., Whitaker-Menezes D., Lin Z., Martinez-Outschoorn U. E., Tanowitz H. B., Al-Zoubi M. S., Howell A., Pestell R. G., Sotgia F., Lisanti M. P., Two-compartment tumor metabolism: autophagy in the tumor microenvironment and oxidative mitochondrial metabolism (OXPHOS) in cancer cells. Cell Cycle 11 13 2545 2556
82. Balliet R. M., Capparelli C., Guido C., Pestell T. G., Martinez-Outschoorn U. E., Lin Z., Whitaker-Menezes D., Chiavarina B., Pestell R. G., Howell A., Sotgia F., Lisanti M. P., Mitochondrial oxidative stress in cancer-associated fibroblasts drives lactate production, promoting breast cancer tumor growth: understanding the aging and cancer connection. Cell Cycle 2011 10 23 4065 4073 2-s2.0-82855170859 10.4161/cc.10.23.18254
83. Henze A.-T., Acker T., Feedback regulators of hypoxia-inducible factors and their role in cancer biology. Cell Cycle 2010 9 14 2749 2763 2-s2.0-77956805884 10.4161/cc.9.14.12249
84. Höckel M., Vaupel P., Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. Journal of the National Cancer Institute 2001 93 4 266 276 2-s2.0-0035925098 (Pubitemid 32219813)
85. Amelio I., Melino G., The "Sharp" blade against HIF-mediated metastasis. Cell Cycle 11 24 4530 4535
86. Briston T., Yang J., Ashcroft M., HIF-1 α localization with mitochondria: a new role for an old favorite? Cell Cycle 2011 10 23 4170 4171 2-s2.0-82855181978 10.4161/cc.10.23.18565
87. Bertozzi D., Iurlaro R., Sordet O., Marinello J., Zaffaroni N., Capranico G., Characterization of novel antisense HIF-1 α transcripts in human cancers. Cell Cycle 2011 10 18 3189 3197 2-s2.0-80052885284 10.4161/cc.10.18. 17183
88. Rapisarda A., Shoemaker R. H., Melillo G., Antiangiogenic agents and HIF-1 inhibitors meet at the crossroads. Cell Cycle 2009 8 24 4040 4043 2-s2.0-74849127957
89. Maxwell P. H., HIF-1's relationship to oxygen: simple yet sophisticated. Cell Cycle 2004 3 2 156 159 2-s2.0-3843095197 (Pubitemid 40268688)
90. Ma J., Zhang Q., Chen S., Mitochondrial dysfunction promotes breast cancer cell migration and invasion through HIF1alpha accumulation via increased production of reactive oxygen species. PLoS ONE 2013 8 7 e69485
91. Compton S., Kim C., Griner N. B., Potluri P., Scheffler I. E., Sen S., Jerry D. J., Schneider S., Yadava N., Mitochondrial dysfunction impairs tumor suppressor p53 expression/function. Journal of Biological Chemistry 2011 286 23 20297 20312 2-s2.0-79957994581 10.1074/jbc.M110.163063
92. Schwartzenberg-Bar-Yoseph F., Armoni M., Karnieli E., The tumor suppressor p53 down-regulates glucose transporters GLUT1 and GLUT4 gene expression. Cancer Research 2004 64 7 2627 2633 2-s2.0-1942506067 10.1158/0008-5472.CAN-03-0846 (Pubitemid 38523921)
93. Szatrowski T. P., Nathan C. F., Production of large amounts of hydrogen peroxide by human tumor cells. Cancer Research 1991 51 3 794 798 2-s2.0-0026021362
94. Moreno-Sánchez R., Rodríguez-Enríquez S., Marín-Hernández A., Saavedra E., Energy metabolism in tumor cells. FEBS Journal 2007 274 6 1393 1418 2-s2.0-33847367741 10.1111/j.1742-4658.2007. 05686.x (Pubitemid 46333738)
95. Pelicano H., Martin D. S., Xu R.-H., Huang P., Glycolysis inhibition for anticancer treatment. Oncogene 2006 25 34 4633 4646 2-s2.0-33746879141 10.1038/sj.onc.1209597 (Pubitemid 44187614)
96. Bauer G., Tumor cell-protective catalase as a novel target for rational therapeutic approaches based on specific intercellular ROS signaling. Anticancer Research 32 7 2599 2624
97. Ishikawa K., Takenaga K., Akimoto M., Koshikawa N., Yamaguchi A., Imanishi H., Nakada K., Honma Y., Hayashi J.-I., ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 2008 320 5876 661 664 2-s2.0-43249112094 10.1126/science.1156906 (Pubitemid 351928347)
98. Carew J. S., Zhou Y., Albitar M., Carew J. D., Keating M. J., Huang P., Mitochondrial DNA mutations in primary leukemia cells after chemotherapy: clinical significance and therapeutic implications. Leukemia 2003 17 8 1437 1447 2-s2.0-0043029566 10.1038/sj.leu.2403043 (Pubitemid 36986944)
99. Indo H. P., Davidson M., Yen H.-C., Suenaga S., Tomita K., Nishii T., Higuchi M., Koga Y., Ozawa T., Majima H. J., Evidence of ROS generation by mitochondria in cells with impaired electron transport chain and mitochondrial DNA damage. Mitochondrion 2007 7 1-2 106 118 2-s2.0-33847683419 10.1016/j.mito.2006.11.026 (Pubitemid 46351959)
100. Tan D.-J., Bai R.-K., Wong L.-J. C., Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Research 2002 62 4 972 976 2-s2.0-0036170578 (Pubitemid 34160271)
101. Polyak K., Li Y., Zhu H., Lengauer C., Willson J. K. V., Markowitz S. D., Trush M. A., Kinzler K. W., Vogelstein B., Somatic mutations of the mitochondrial genome in human colorectal tumours. Nature Genetics 1998 20 3 291 293 2-s2.0-0031736203 10.1038/3108 (Pubitemid 28507677)
102. Liu V. W., Shi H. H., Cheung A. N., Chiu P. M., Leung T. W., Nagley P., Wong L. C., Ngan H. Y., High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Research 2001 61 16 5998 6001 2-s2.0-0035882029 (Pubitemid 32762527)
103. Sanchez-Cespedes M., Parrella P., Nomoto S., Cohen D., Xiao Y., Esteller M., Jeronimo C., Jordan R. C. K., Nicol T., Koch W. M., Schoenberg M., Mazzarelli P., Fazio V. M., Sidransky D., Identification of a mononucleotide repeat as a major target for mitochondrial DNA alterations in human tumors. Cancer Research 2001 61 19 7015 7019 2-s2.0-0035476227 (Pubitemid 32946487)
104. Fliss M. S., Usadel H., Caballero O. L., Wu L., Buta M. R., Eleff S. M., Jen J., Sidransky D., Facile detection of mitochondrial DNA mutations in tumors and bodily fluids. Science 2000 287 5460 2017 2019 2-s2.0-0039250954 10.1126/science.287.5460.2017 (Pubitemid 30158678)
105. Reed J. C., Molecular biology of chronic lymphocytic leukemia. Seminars in Oncology 1998 25 1 11 18 2-s2.0-0031890032 (Pubitemid 28090907)
106. Sharief M. K., Douglas M., Noori M., Semra Y. K., The expression of pro- and anti-apoptosis Bcl-2 family proteins in lymphocytes from patients with multiple sclerosis. Journal of Neuroimmunology 2002 125 1-2 155 162 2-s2.0-0036228050 10.1016/S0165-5728(02)00024-3 (Pubitemid 34327465)
107. Heiser D., Labi V., Erlacher M., Villunger A., The Bcl-2 protein family and its role in the development of neoplastic disease. Experimental Gerontology 2004 39 8 1125 1135 2-s2.0-3543123595 10.1016/j.exger.2004.04.011 (Pubitemid 39024362)
108. Takeuchi O., Fisher J., Suh H., Harada H., Malynn B. A., Korsmeyer S. J., Essential role of BAX,BAK in B cell homeostasis and prevention of autoimmune disease. Proceedings of the National Academy of Sciences of the United States of America 2005 102 32 11272 11277 2-s2.0-23844433945 10.1073/pnas.0504783102 (Pubitemid 41153810)
109. Traver D., Akashi K., Weissman I. L., Lagasse E., Mice defective in two apoptosis pathways in the myeloid lineage develop acute myeloblastic leukemia. Immunity 1998 9 1 47 57 2-s2.0-0032126364 10.1016/S1074-7613(00)80587-7 (Pubitemid 28361294)
110. Schumacher B., Hofmann K., Boulton S., Gartner A., The C. elegans homolog of the p53 tumor suppressor is required for DNA damage-induced apoptosis. Current Biology 2001 11 21 1722 1727 2-s2.0-0035975986 10.1016/S0960-9822(01) 00534-6 (Pubitemid 33037787)
111. Baur J. A., Pearson K. J., Price N. L., Jamieson H. A., Lerin C., Kalra A., Prabhu V. V., Allard J. S., Lopez-Lluch G., Lewis K., Pistell P. J., Poosala S., Becker K. G., Boss O., Gwinn D., Wang M., Ramaswamy S., Fishbein K. W., Spencer R. G., Lakatta E. G., Le Couteur D., Shaw R. J., Navas P., Puigserver P., Ingram D. K., De Cabo R., Sinclair D. A., Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006 444 7117 337 342 2-s2.0-33751072349 10.1038/nature05354 (Pubitemid 44764104)
112. Pearson K. J., Baur J. A., Lewis K. N., Peshkin L., Price N. L., Labinskyy N., Swindell W. R., Kamara D., Minor R. K., Perez E., Jamieson H. A., Zhang Y., Dunn S. R., Sharma K., Pleshko N., Woollett L. A., Csiszar A., Ikeno Y., Le Couteur D., Elliott P. J., Becker K. G., Navas P., Ingram D. K., Wolf N. S., Ungvari Z., Sinclair D. A., de Cabo R., Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metabolism 2008 8 2 157 168 2-s2.0-48349144852 10.1016/j.cmet.2008.06.011
113. Lagouge M., Argmann C., Gerhart-Hines Z., Meziane H., Lerin C., Daussin F., Messadeq N., Milne J., Lambert P., Elliott P., Geny B., Laakso M., Puigserver P., Auwerx J., Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1 α Cell 2006 127 6 1109 1122 2-s2.0-33845399894 10.1016/j.cell.2006.11.013 (Pubitemid 44894520)
114. Milne J. C., Lambert P. D., Schenk S., Carney D. P., Smith J. J., Gagne D. J., Jin L., Boss O., Perni R. B., Vu C. B., Bemis J. E., Xie R., Disch J. S., Ng P. Y., Nunes J. J., Lynch A. V., Yang H., Galonek H., Israelian K., Choy W., Iffland A., Lavu S., Medvedik O., Sinclair D. A., Olefsky J. M., Jirousek M. R., Elliott P. J., Westphal C. H., Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature 2007 450 7170 712 716 2-s2.0-36749087548 10.1038/nature06261 (Pubitemid 350207685)
115. Winder W. W., Holmes B. F., Rubink D. S., Jensen E. B., Chen M., Holloszy J. O., Activation of AMP-activated protein kinase increases mitochondrial enzymes in skeletal muscle. Journal of Applied Physiology 2000 88 6 2219 2226 2-s2.0-0033949848 (Pubitemid 30453931)
116. Fujii N., Jessen N., Goodyear L. J., AMP-activated protein kinase and the regulation of glucose transport. The American Journal of Physiology 2006 291 5 E867 E877 2-s2.0-33751195101 10.1152/ajpendo.00207.2006
117. Ruderman N. B., Saha A. K., Kraegen E. W., Minireview: malonyl CoA, AMP-activated protein kinase, and adiposity. Endocrinology 2003 144 12 5166 5171 2-s2.0-0345374578 10.1210/en.2003-0849 (Pubitemid 37476042)
118. Mayers R. M., Leighton B., Kilgour E., PDH kinase inhibitors: a novel therapy for Type II diabetes? Biochemical Society Transactions 2005 33 2 367 370 2-s2.0-18044384124 10.1042/BST0330367 (Pubitemid 40604374)
119. Fink B. D., O'Malley Y., Dake B. L., Ross N. C., Prisinzano T. E., Sivitz W. I., Mitochondrial targeted coenzyme Q, superoxide, and fuel selectivity in endothelial cells. PLoS ONE 2009 4 1 2-s2.0-64149103303 10.1371/journal.pone. 0004250 e4250
120. Yorek M. A., The role of oxidative stress in diabetic vascular and neural disease. Free Radical Research 2003 37 5 471 480 2-s2.0-0037402505 10.1080/1071576031000083161 (Pubitemid 36410886)
121. Maguire J. J., Wilson D. S., Packer L., Mitochondrial electron transport-linked tocopheroxyl radical reduction. Journal of Biological Chemistry 1989 264 36 21462 21465 2-s2.0-0024832264 (Pubitemid 20028701)
122. Yi X., Maeda N., α -Lipoic acid prevents the increase in atherosclerosis induced by diabetes in apolipoprotein E-deficient mice fed high-fat/low-cholesterol diet. Diabetes 2006 55 8 2238 2244 2-s2.0-33749363594 10.2337/db06-0251 (Pubitemid 44743620)
123. Mehta K., van Thiel D. H., Shah N., Mobarhan S., Nonalcoholic fatty liver disease: pathogenesis and the role of antioxidants. Nutrition Reviews 2002 60 9 289 293 2-s2.0-0036718446 10.1301/002966402320387224 (Pubitemid 35025794)
124. Li M., Peterson S., Husney D., Inaba M., Guo K., Eri T., Morita T., Patil K., Kappas A., Ikehara S., Abraham N. G., Interdiction of the diabetic state in NOD mice by sustained induction of heme oxygenase: possible role of carbon monoxide and bilirubin. Antioxidants and Redox Signaling 2007 9 7 855 863 2-s2.0-34250343823 10.1089/ars.2007.1568 (Pubitemid 46919588)
125. Kelso G. F., Porteous C. M., Coulter C. V., Hughes G., Porteous W. K., Ledgerwood E. C., Smith R. A. J., Murphy M. P., Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. Journal of Biological Chemistry 2001 276 7 4588 4596 2-s2.0-0035895888 10.1074/jbc.M009093200
126. Adlam V. J., Harrison J. C., Porteous C. M., James A. M., Smith R. A. J., Murphy M. P., Sammut I. A., Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. The FASEB Journal 2005 19 9 1088 1095 2-s2.0-21744450416 10.1096/fj.05-3718com (Pubitemid 40946434)
127. Jauslin M. L., Meier T., Smith R. A., Murphy M. P., Mitochondria-targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. The FASEB Journal 2003 17 13 1972 1974
128. Saretzki G., Murphy M. P., von Zglinicki T., MitoQ counteracts telomere shortening and elongates lifespan of fibroblasts under mild oxidative stress. Aging Cell 2003 2 2 141 143 2-s2.0-0041419866
129. Dhanasekaran A., Kotamraju S., Kalivendi S. V., Matsunaga T., Shang T., Keszler A., Joseph J., Kalyanaraman B., Supplementation of endothelial cells with mitochondria-targeted antioxidants inhibit peroxide-induced mitochondrial iron uptake, oxidative damage, and apoptosis. Journal of Biological Chemistry
130. Schäfer M., Schäfer C., Ewald N., Piper H. M., Noll T., Role of redox signaling in the autonomous proliferative response of endothelial cells to hypoxia. Circulation Research 2003 92 9 1010 1015 2-s2.0-0038025936 10.1161/01.RES.0000070882.81508.FC (Pubitemid 36588500)
131. Knowler W. C., Barrett-Connor E., Fowler S. E., Hamman R. F., Lachin J. M., Walker E. A., Nathan D. M., Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. The New England Journal of Medicine 2002 346 6 393 403 2-s2.0-0037034257 10.1056/NEJMoa012512 (Pubitemid 34437694)
132. Henriksen E. J., Invited review: effects of acute exercise and exercise training on insulin resistance. Journal of Applied Physiology 2002 93 2 788 796 2-s2.0-0036021855 (Pubitemid 34810247)
133. Reznick R. M., Shulman G. I., The role of AMP-activated protein kinase in mitochondrial biogenesis. Journal of Physiology 2006 574 1 33 39 2-s2.0-33745215883 10.1113/jphysiol.2006.109512 (Pubitemid 43905794)
134. Röckl K. S. C., Witczak C. A., Goodyear L. J., Signaling mechanisms in skeletal muscle: acute responses and chronic adaptations to exercise. IUBMB Life 2008 60 3 145 153 2-s2.0-44049092767 10.1002/iub.21
135. Fulda S., Exploiting mitochondrial apoptosis for the treatment of cancer. Mitochondrion 2010 10 6 598 603 2-s2.0-78149359030 10.1016/j.mito.2010.05.001
136. Hagland H., Nikolaisen J., Hodneland L. I., Gjertsen B. T., Bruserud Ø., Tronstad K. J., Targeting mitochondria in the treatment of human cancer: a coordinated attack against cancer cell energy metabolism and signalling. Expert Opinion on Therapeutic Targets 2007 11 8 1055 1069 2-s2.0-34547785566 10.1517/14728222.11.8.1055 (Pubitemid 47232621)
137. Bonnet S., Archer S. L., Allalunis-Turner J., Haromy A., Beaulieu C., Thompson R., Lee C. T., Lopaschuk G. D., Puttagunta L., Bonnet S., Harry G., Hashimoto K., Porter C. J., Andrade M. A., Thebaud B., Michelakis E. D., A mitochondria-K+ channel axis is suppressed in cancer and its normalization promotes apoptosis and inhibits cancer growth. Cancer Cell 2007 11 1 37 51 2-s2.0-33846002728 10.1016/j.ccr.2006.10.020 (Pubitemid 46054520)
138. Schulz T. J., Thierbach R., Voigt A., Drewes G., Mietzner B., Steinberg P., Pfeiffer A. F. H., Ristow M., Induction of oxidative metabolism by mitochondrial frataxin inhibits cancer growth: otto Warburg revisited. Journal of Biological Chemistry 2006 281 2 977 981 2-s2.0-33644868755 10.1074/jbc.M511064200
139. Holinger E. P., Chittenden T., Lutz R. J., Bak BH3 peptides antagonize Bcl-x(L) function and induce apoptosis through cytochrome c-independent activation of caspases. Journal of Biological Chemistry 1999 274 19 13298 13304 2-s2.0-0033531926 10.1074/jbc.274.19.13298 (Pubitemid 29220460)